Projects per year
Personal profile
Biography
I am Pharmacologist interested in analgesics and other psychoactive drugs, particularly cannabinoids and opioids. My lab studies how opioids, cannabinoids and related molecules interact with G protein coupled receptors and ion channels to exert their effects. Currently my work is focussed on how clinically used opioids interact with naturally occuring variants of human opioid receptors, the pharmacology and toxicity of emerging synthetic cannabinoid receptors agonists (Spice/K2) and the molecular mechanisms underlying the potential therapeutic actions of cannabis and its components.
Education/Academic qualification
Pharmacology, PhD, University of Washington (UW)
Award Date: 18 Dec 1992
Pharmacology, Genetics, BSc (Hons), University of Sydney
Award Date: 25 May 1988
Fingerprint
Dive into the research topics where Mark Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
BDRC: Biomolecular Discovery Research Centre
Sunna, A., Packer, N., Paulsen, I., Guillemin, G., Li, M., Sofronov, G., Haynes, P., Mabbutt, B., Tetu, S., Thaysen-Andersen, M., Ponton, F., Garcia-Bennett, A., Wang, Y., Cain, A., Kroukamp, H., Maselko, M., Francis, H., Liquet-Weiland, B., Rodger, A., Lee, A., Connor, M., Inglis, D., Carthey, A. & Asadniaye Fard Jahromi, M.
1/01/20 → 31/12/22
Project: Other
-
Development of next-generation targeted therapies for epilepsy and pain based on cannabinoid derivatives
Bladen, C. & Connor, M.
3/07/17 → …
Project: Research
-
Advanced protein quantification capability
Walker, A. K., Lee, A., Connor, M., Atkin, J., Lim, E., Baker, M. S., Rizos, H., Phillips, J. K., Yang, S. & Blair, I.
1/01/17 → …
Project: Research
-
Mechanisms underlying the repellent effects of predator odours in rodents
Connor, M., McGregor, I., Crowther, M. & Banister, S.
1/01/16 → …
Project: Research
Research Outputs
-
A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders
Kisely, S., Connor, M., Somogyi, A. A. & Siskind, D., 12 Mar 2022, (E-pub ahead of print) In: Australian & New Zealand Journal of Psychiatry. 17 p.Research output: Contribution to journal › Review article › peer-review
-
Defining steric requirements at CB1 and CB2 cannabinoid receptors using synthetic cannabinoid receptor agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and their analogues
Markham, J., Sparkes, E., Boyd, R., Chen, S., Manning, J., Finlay, D., Lai, F., McGregor, E., Maloney, C. J., Gerona, R. R., Connor, M., McGregor, I. S., Hibbs, D. E., Glass, M., Kevin, R. C. & Banister, S. D., 20 Apr 2022, In: ACS Chemical Neuroscience. 13, 8, p. 1281-1295 15 p.Research output: Contribution to journal › Article › peer-review
-
Employing the operational model to measure system-independent OTR efficacy
Afzali, K. & Connor, M., 2022, Oxytocin: methods and protocols. Werry, E. L., Reekie, T. A. & Kassiou, M. (eds.). New York, NY: Humana Press, p. 201-220 20 p. (Methods in Molecular Biology; vol. 2384).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro
Mirlohi, S., Bladen, C., Santiago, M. J., McGregor, I. S., Arnold, J. C. & Connor, M., Aug 2022, In: British Journal of Pharmacology. 179, 15, p. 4031-4043 13 p., 15842.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Modulation of recombinant human T-type calcium channels by Δ9-tetrahydrocannabinolic acid in vitro
Mirlohi, S., Bladen, C., Santiago, M. & Connor, M., Feb 2022, In: Cannabis and Cannabinoid Research. 7, 1, p. 34-45 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)